Contract pharmaceutical company in the US Patheon has sold its global secondary clinical packaging and clinical distribution services business to Bellwyck Packaging Solutions for an undisclosed sum.
Patheon chief executive officer James Mullen said the terms of the transaction are not expected to have a material impact on the company’s on-going results and the transaction is part of its continued focus on its core competencies of solid-dose and parenteral development and manufacturing.
"One of Bellwyck’s core competencies is clinical packaging," Mullen said.
Patheon’s secondary clinical packaging and clinical distribution services business includes an operating presence in Cincinnati, Ohio, US and is globally managed from its Burlington, Ontario, Canada facility.
Canadian healthcare and packaging supplier Bellwyck Packaging Solutions provides clinical trial and contract services for secondary packaging.